IRIS Accounts Production v24.3.0.553 07801693 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false 'A' Ordinary 1.00000 'B' Ordinary 1.00000 'A' Ordinary 1.00000 'B' Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078016932023-01-31078016932024-01-31078016932023-02-012024-01-31078016932022-01-31078016932022-02-012023-01-31078016932023-01-3107801693ns15:EnglandWales2023-02-012024-01-3107801693ns14:PoundSterling2023-02-012024-01-3107801693ns10:Director12023-02-012024-01-3107801693ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107801693ns10:SmallEntities2023-02-012024-01-3107801693ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3107801693ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3107801693ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3107801693ns10:AbridgedAccounts2023-02-012024-01-3107801693ns10:OrdinaryShareClass22023-02-012024-01-3107801693ns10:OrdinaryShareClass32023-02-012024-01-3107801693ns10:Director22023-02-012024-01-3107801693ns10:RegisteredOffice2023-02-012024-01-3107801693ns5:CurrentFinancialInstruments2024-01-3107801693ns5:CurrentFinancialInstruments2023-01-3107801693ns5:ShareCapital2024-01-3107801693ns5:ShareCapital2023-01-3107801693ns5:RetainedEarningsAccumulatedLosses2024-01-3107801693ns5:RetainedEarningsAccumulatedLosses2023-01-3107801693ns5:ComputerEquipment2023-02-012024-01-3107801693ns5:DeferredTaxation2023-01-3107801693ns5:DeferredTaxation2023-02-012024-01-3107801693ns5:DeferredTaxation2024-01-3107801693ns10:OrdinaryShareClass22024-01-3107801693ns10:OrdinaryShareClass32024-01-31
REGISTERED NUMBER: 07801693 (England and Wales)















Medical and General Consulting Ltd

Unaudited Financial Statements for the Year Ended 31 January 2024






Medical and General Consulting Ltd (Registered number: 07801693)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


Medical and General Consulting Ltd

Company Information
for the Year Ended 31 January 2024







DIRECTORS: C A Lambourne
Dr B L Hillier





REGISTERED OFFICE: 4 King Square
Bridgwater
Somerset
TA6 3YF





REGISTERED NUMBER: 07801693 (England and Wales)





ACCOUNTANTS: Maxwells
Chartered Accountants
4 King Square
Bridgwater
Somerset
TA6 3YF

Medical and General Consulting Ltd (Registered number: 07801693)

Abridged Statement of Financial Position
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 1,674 1,783

CURRENT ASSETS
Debtors 59,406 60,878
Cash at bank 259,891 216,520
319,297 277,398
CREDITORS
Amounts falling due within one year 24,139 21,446
NET CURRENT ASSETS 295,158 255,952
TOTAL ASSETS LESS CURRENT
LIABILITIES

296,832

257,735

PROVISIONS FOR LIABILITIES 6 318 339
NET ASSETS 296,514 257,396

CAPITAL AND RESERVES
Called up share capital 7 1,000 1,000
Retained earnings 295,514 256,396
SHAREHOLDERS' FUNDS 296,514 257,396

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medical and General Consulting Ltd (Registered number: 07801693)

Abridged Statement of Financial Position - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 October 2024 and were signed on its behalf by:





Dr B L Hillier - Director


Medical and General Consulting Ltd (Registered number: 07801693)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Medical and General Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents invoiced provision of services net of flat rate value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

Medical and General Consulting Ltd (Registered number: 07801693)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023 3,336
Additions 2,511
Disposals (3,336 )
At 31 January 2024 2,511
DEPRECIATION
At 1 February 2023 1,553
Charge for year 836
Eliminated on disposal (1,552 )
At 31 January 2024 837
NET BOOK VALUE
At 31 January 2024 1,674
At 31 January 2023 1,783

6. PROVISIONS FOR LIABILITIES
31.1.24 31.1.23
£    £   
Deferred tax 318 339

Deferred
tax
£   
Balance at 1 February 2023 339
Utilised during year (21 )
Balance at 31 January 2024 318

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
500 'A' Ordinary £1 500 500
500 'B' Ordinary £1 500 500
1,000 1,000

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr C Lambourne and Dr B Hillier.